The role of the classical complement pathway and specifically the first component, Cl in antibodyindependent opsonization of type Ia group B Streptococcus (GBS) was investigated. For these studies a radiolabeled bacterial uptake assay was developed that was dependent on time and bacterial concentration and that required an intact classical complement pathway. To directly investigate the role of Cl in opsonization of type Ia GBS, Cl was isolated by chromatography on an immunoglobulin G (IgG) affinity column and further purified by molecular sieve chromatography on an Ultrogel AcA 22 column. When normal human serum was adsorbed with 109 CFU of type Ia or III GBS, the serum opsonic capacity diminished (33 to 34%) for type Ia GBS compared with unadsorbed serum. Preincubation of the bacteria with purified Cl (104 U of Cl per ml) restored the opsonizing capacity of the adsorbed serum. A Cl-depleted serum was prepared from the nonadherent fractions of the CH-sepharose 4B IgG column which only contained 5 U of Cl per ml. Substitution of C1-depleted reagent for normal serum in the uptake assay resulted in dramatic decreases in the opsonization of type Ia GBS, but opsonization could be restored by preincubation of the bacteria with purified Cl. Heat-inactivated Cl depleted serum did not support opsonization of type Ia GBS, even with the addition of Cl. Preincubation of type Ia GBS with heat-inactivated hyperimmune sera did not result in opsonization of type Ta GBS in the presence of Cl-depleted serum. However, opsonization could be restored by the addition of Cl, and the effects of Cl and antibody were additive. These results indicate the critical role of Cl in direct activation of the classical complement pathway by type Ia GBS and in antibody-mediated opsonization of the bacteria.
The classical complement pathway is a critical element in immunity to extracellular pathogens such as group B Streptococcus (GBS). One serotype of GBS, type la, has been documented to activate directly the classical complement pathway in human serum (4, 9) . In the initial observation, 18 fresh clinical isolates of type Ta GBS were opsonized and killed by incubation with leukocytes and sera devoid of type-specific antibody (4) . The mechanism of direct activation by the bacteria was not examined, but there was indirect evidence for the role of the classical complement pathway binding and triggering component, Cl. In opsonophagocytosis of type Ta GBS there was an absolute requirement for C2, a substrate of Cl (9) . Furthermore, the opsonization of type Ia GBS could be decreased by incubation of the serum complement source with the chelating agent, MgEGTA, which depletes serum of Cl activity (4, 9) . Other evidence for the role of Cl in the opsonization of type la GBS have come from our studies on complement activation by purified GBS capsular polysaccharides (15) . When human serum was incubated with purified GBS capsular polysaccharides, complement-mediated opsonophagocytic killing of type Ia GBS was dramatically decreased. Measurement of the complement component levels in the serum after incubation with the polysaccharides revealed alterations in functional levels of both Cl and C4. Results of these previous studies have implicated the requirement for Cl in the opsonization of type Ta GBS through direct activation of the classical complement pathway and have led us to our present investigations.
We developed a radiolabeled bacterial uptake assay to define the mechanism by which type Ta GBS directly activates the classical complement pathway. This opsonization assay requires an intact classical pathway and similar ratios * Corresponding author.
of reactants, as were required in the opsonophagocytic killing assay described earlier. To investigate directly the role of Cl in initiating the opsonization of type Ta GBS, we purified Cl from serum and prepared a Cl-depleted reagent. Results of studies with the Cl-depleted reagent revealed decreased opsonization of type Ia GBS, which could be restored to normal levels with the addition of purified Cl. In further studies Cl was also found to be a necessary component for the optimal opsonization of type Ia GBS in the presence of type-specific antibody.
MATERIALS AND METHODS
GBS strains and growth conditions. Type la strain 515 and type III strain M732, both originally clinical isolates, were obtained from the culture collection at the Channing Laboratory. The organisms had been stored at -70°C in 0.5 ml of Todd-Hewitt broth (THB; Difco Laboratories, Detroit, Mich.). For the opsonophagocytic assay, GBS were grown into early log-phase, pelleted at 8,000 x g, and suspended in minimal essential medium (MEM) to achieve a concentration of 2 x 107 CFU/ml of MEM (9) . For adsorption experiments bacteria were grown as described above, and a small fraction was diluted serially for determination of the CFU. The remainder of the suspension was pelleted at 8,000 x g, washed once in saline, lyophilized, and stored in dessicated form at room temperature (23°C) (9) . Bacteria were quantitated by assuming that the total yield in weight corresponded to the total number of CFU before lyophilization.
Human sera. Normal human serum was obtained from the blood of healthy volunteers that worked in the laboratory. (9) .
Cl purification and Cl-depleted reagent. The purification utilized the procedure of Medicus and Chapuis (17) and was based on the ability of Cl to bind immobilized IgG. Human immunoglobulin was coupled to a CH-Sepharose 4B column using carbodiimide (Pharmacia Fine Chemicals, Piscataway, N.J.). The running buffer for the column (2.4 by 9 cm) was composed of one part GVB + + and one part GVB + + containing 1.4 M sucrose (16) Buchner funnel. After the filters were washed extensively with saline, they were transferred to scintillation vials, and 1 ml of protosol (New England Nuclear) was added. After overnight digestion, 10 ml of liquifluor toluene (New England Nuclear) was added, and the samples were counted in a Packard Tri-Carb 4530 (Packard Instrument Co., Downers Grove, Ill.). The results were expressed as the percentage change in counts associated with PMNs compared with a normal serum control accordini to the following formula:
(experimental cpm -background cpm)/(control cpmbackground cpm) x 100. Adsorption of serum with bacteria or MgEGTA. In some experiments sera were first adsorbed with bacteria. Lyophilized strain 515 or M732 were diluted in 0.01 ml of saline and mixed with human serum to yield 109 CFU/ml of serum. The control was to add an equivalent amount of saline to the serum instead of bacteria. After adsorption for 30 min on ice, bacteria were removed by centrifugation, and the adsorbed sera were used in the uptake and killing assays described above.
In studies in which the classical pathway of complement was inhibited by chelation with MgEGTA, the experimental procedure was modified to include a preopsonization step to avoid toxicity to the leukocytes (9) . Serum diluted in either MgEGTA or GVB"+ (control) were incubated for 5 min at 37°C, and the bacteria were added (0.1 ml of a suspension ofcomponents in the opsonization of type Ta GBS, a critical variable has been the ratio of bacteria to leukocytes. Results of previous studies from our laboratory have employed a bacteria to leukocyte ratio of 3:1. To establish the optimum proportions of these reactants in a complement-dependent radiolabeled bacterial uptake assay, increasing numbers of 3H-labeled type Ta GBS were incubated with PMNs and normal human serum for 30 min. Bacterial uptake by leukocytes increased dramatically in direct relation to the number of organisms in the reaction mixture (Fig. 1) . As assessed by specific activity when 5 x 106 CFU were in the reaction mixture, 4 x 105 CFU were associated with leukocytes in the presence of normal human serum. To assess the role of complement in this uptake assay, the serum was first heat-inactivated at 56°C for 30 min and used in the uptake assay with the same bacteria to leukocyte ratio. This complement depletion resulted in a large decrease in the association of bacteria and leukocytes (Fig. 1) .
The classical complement pathway is required for opsonophagocytic killing of type Ia GBS in the absence of type-specific antibody (4, 9) . To determine whether the complement-mediated uptake of 3H-labeled type Ia GBS by leukocytes is also due to the classical pathway, serum was diluted with MgEGTA buffer and used as the complement source in the uptake assay. This resulted in a 84 ± 2% decrease in association of 3H-labeled type Ta GBS with leukocytes. Cl is the complement component most affected by the availability of Ca2+. Therefore, the radiolabeled uptake assay requires the classical complement pathway, most likely Cl.
Opsonophagocytosis of type Ia GBS is a time-dependent phenomena. To determine the optimal incubation time for the complement-mediated opsonization and uptake of 3H-labeled type la GBS, bacteria and leukocytes were incubated with normal human serum for various periods of time. When the amount of radioactivity associated with the cells was measured, there was a direct relation between the time of incubation and the amount of type Ia GBS associated with requires an intact classical complement pathway, specifically the first component, Cl. The functional role of Cl in the opsonization of type Ia GBS was studied by purifying Cl from normal human serum by immunoadsorption on a CHSepharose 4B IgG affinity column. Cl was eluted from the column with GVB++ containing 0.4 M NaCl and further purified on Ultrogel AcA 22. Figure 3 represents a typical protein profile obtained from the fractions collected from the gel filtration column. Fractions were tested for functional Cl activity by hemolytic titration with EAC4 cells. The peak of Cl activity coincided with a small protein peak at fraction 64 and contained 2,400 U of Cl per ml. Cl requirements for opsonization of type Ta. In previous studies of complement activation by type Ta GBS, we were unable to adsorb serum with GBS to demonstrate the complete antibody independence of the system. Although attempts at adsorption with whole bacteria resulted in decreased opsonization, we were unable to determine whether this was due to a decrease in Cl or to a decrease in type-specific antibody. This altered opsonic capacity occurs after adsorption of serum with either type Ia or III GBS. The observed decreased opsonic activity with both GBS serotypes suggested that the effect was not the result of adsorption of a specific antibody but perhaps the loss of another opsonin such as a complement component. Serum was adsorbed for 10 min on ice with 109 CFU of type Ia or III GBS per ml of serum. After removal of the bacteria by centrifugation, the preadsorbed sera were used as the complement source in the uptake assay and were found to have a diminished opsonic capacity for 3H-labeled type Ia GBS of 33 to 34% (Table 2) .
To determine whether Cl had been affected by the adsorption, purified Cl was employed. 3H-labeled type Ta GBS were incubated with purified Cl and then used in the uptake assay. Use of these Cl-incubated bacteria with the adsorbed serum as the complement source in the uptake assay resulted in no decrease in association of the 3H-labeled type Ta GBS with the leukocytes compared with the normal unadsorbed serum control (Table 2) . Thus, GBS appears to adsorb a critical complement component out of normal human serum, diminishing the opsonic capacity of the serum, but this activity could be replenished by the addition of purified Cl. The extensive adsorption of our complement source with whole GBS (109) coupled with the complete restoration of the opsonization capacity of this adsorbed serum by pure Cl is strong evidence for the direct activation of Cl by GBS in the absence of antibody.
Cl-depleted serum was also employed as a complement source, instead of normal human serum, in the uptake assay to prove that Cl was a critical component in the classical pathway-mediated opsonization of type Ia. This Cl-depleted reagent was prepared from the nonadherent fractions of the CH-Sepharose 4B IgG column and contained only 5 U of Cl per ml by hemolytic titration with EAC4 cells compared with 80,000 U per ml for the normal serum control. Substitution of the Cl-depleted reagent in the uptake assay compared with normal human serum resulted in dramatic decreases in the association of 3H-labeled type Ia GBS with PMNs (Fig.  4, lane A versus lane B) . Incubation of 3H-labeled type Ia GBS with purified Cl and the subsequent addition of Cldepleted serum and PMNs resulted in the reassociation of bacteria with the leukocytes (Fig. 4, lane C) .
To determine whether complement components after Cl are required for association of bacteria with leukocytes, Cl-opsonized bacteria, heat-inactivated Cl-depleted serum, and leukocytes were employed in an uptake assay. This combination resulted in only 8% association of 3H- Cl and antibody-mediated opsonization. The role of Cl in antibody-mediated opsonization of type Ia GBS was also investigated. 3H-labeled type Ta GBS were opsonized with undiluted, heat-inactivated, hyperimmune rabbit antiserum and used in the uptake assay with Cl-depleted serum as the complement source (Fig. 4, lane D) . This did not increase the uptake of type Ia bacteria when compared with the Cldepleted normal human serum control (Fig. 4, lane B) . In contrast, if the bacteria were first opsonized with antibody and then with purified Cl, opsonization was restored (Fig. 4, 
lane E).
To determine whether the observed increase in association of bacteria with PMNs was due to both Cl and antibody, Cl was diluted to allow the additive effects of Cl and antibody to be examined. The association of type Ia GBS and leukocyte was 28 ± 5% in Cl-depleted serum with undiluted type Ia antibody. When 3H-labeled type Ia GBS were incubated with a 1:4 dilution of our Cl (2.5 x 103 U/5
x 107 CFU) but without antibody, there was 39 ± 0.5% association of bacteria with the leukocytes in the presence of Cl-depleted serum. However, if 3H-labeled type Ta GBS were opsonized with antibody and Cl, the association of the bacteria increased to 55 ± 3%. Therefore, Cl is required for both antibody-independent and -dependent opsonization of type Ia GBS.
DISCUSSION
Results of our previous studies have documented the role of the classical complement pathway in opsonophagocytic killing of type Ta GBS (4, 9, 15). The initial observation made by Baker et al. (4) was that when 18 fresh clinical isolates of type Ia GBS were incubated with leukocytes and serum devoid of type-specific antibody, the bacteria were opsonized and killed. The role of the classical complement pathway in opsonization of type Ta GBS was documented by the dramatic decreases in opsonophagocytosis of a representative clinical isolate of type Ia GBS, strain 515, in serum deficient in C2 or chelated with MgEGTA (4, 9) . Results of these studies indicate that Cl has a role in initiating opsonization because Cl is the component most affected by MgEGTA chelation (14) . In examining whether type Ta GBS and Cl could directly interact, a Cl transfer assay was used (8, 9) . This assay measures the capacity of an organism to bind purified Cl and transfer it to recipient indicator cells, sheep erythrocytes sensitized with C4. It was found that binding and transfer of Cl was directly related to the number of bacteria that interacted with Cl (9). Additional evidence for the role of Cl in initiating opsonization of type Ia GBS came from our studies on complement activation by purified GBS capsular polysaccharides (15) . When human serum was incubated with purified GBS capsular polysaccharides, complement-mediated opsonophagocytic killing of type Ia GBS was dramatically decreased. Measurement of the complement component levels in the serum after incubation with polysaccharides revealed alterations in functional levels of both Cl and C4. Results of these studies implicate the requirement for Cl in initiating opsonization of type Ia GBS and led us to our present investigations of the direct requirement for Cl in opsonization of these bacteria.
To study the role of Cl in antibody-independent opsonization of type Ta GBS, we developed a radiolabeled bacterial uptake assay. This opsonization assay requires an intact classical complement pathway and similar ratios of reactants, as are required in the opsonophagocytic killing assay described previously (4, 9, 15) . The advantage of the uptake assay over the opsonophagocytic killing assay is that it separates the first phase of opsonophagocytosis (opsonization) from the second phse (intracellular killing). The separation of these phases is important in view of the findings of other workers that opsonins are important for both steps of opsonophagocytosis. For example, the presence of C3b on the surface of Staphylococcus aureus and Escherichia coli was found to be necessary for the intracellular killing of these bacteria (13) . Although this is the first antibodyindependent, complement-dependent, radiolabeled bacterial uptake assay described for GBS, other workers have reported on antibody-dependent radiolabeled bacterial uptake assays. These include the study of opsonization of 3H-labeled type Ta GBS by alveolar macrophages (2) and the uptake of 3H-labeled type III GBS by leukocytes (1) . The uptake of type Ia GBS by macrophage in the presence of high concentrations of type-specific antibody did not require complement (2); however, the optimal uptake of type III GBS by leukocytes required a competent classical complement pathway in addition to type-specific antibody (1) .
The role of antibody in opsonization was also examined in our assay by using hyperimmune rabbit antiserum as an opsonic source. Our results indicate that high levels of hyperimmune rabbit antiserum would opsonize type Ta GBS, but never to the extent that occurs if the complement cascade is intact. Furthermore, the combination of both antibody and an intact complement cascade resulted in the greatest opsonization of type Ia GBS. These findings were similar to those of other workers investigating opsonophagocytic killing of type Ta GBS. Results of studies by both Hemming et al. (11) and Baltimore et al., (6) have shown that optimal killing of type Ta GBS occurs in the presence of hyperimmune rabbit antiserum and requires an intact complement cascade.
To directly investigate the role of the classical complement pathway and, specifically, the role of Cl in initiating opsonization of type Ta GBS, purified Cl was necessary. The use of an IgG affinity column to purify Cl takes advantage of the immunochemical recognition of IgG by Cl (7, 17 The finding that type Ia GBS adsorbs a component critical for opsonization out of serum correlates well with our previous findings by use of a Cl transfer assay in which type Ia GBS bound and transferred Cl (9) . It is interesting to speculate that the component that adsorbs Cl is also the Cl binding and triggering site on the surface of type Ta GBS. Although we have not identified the activating site on the surface of type Ia GBS, our previous data on complement activation by purified types Ta and III GBS capsular polysaccharides may be relevant (15) . When these polysaccharides are incubated in human serum, Cl is activated and C4 is depleted, decreasing the opsonic capacity of the serum for type Ia GBS. Whether the capsule on the surface of type Ta GBS is the site for complement activation or for the adsorption of opsonic capacity from the serum must be examined.
In our present investigations we present the first direct evidence for the participation of Cl in antibody-independent opsonization of type Ia GBS. We showed that a Cl-depleted reagent did not support opsonization of the organism but that opsonization could be restored by the addition of physiologically relevant amounts of purified Cl. These experiments also revealed that it is not just the Cl components but a functionally active Cl which is necessary for the initiation of opsonization. With heat-inactivated, Cl-depleted serum as the complement source, Cl could not restore opsonic activity. Therefore, it is not only Cl that is necessary to lead to opsonization of the organisms but, more importantly, a functional Cl which can participate with later complement components for opsonic activity, presumably through C3b deposition. This finding is not surprising in view of our previous data showing the requirments for C2 in opsonization of type Ia GBS (9) . Because Cl is the binding and triggering component of the classical pathway, it appears that type Ia GBS may directly activate the classical pathway by a mechanism similar to an immune complex, that is, through binding and activation of Cl. The failure of Cldepleted serum to initiate opsonization and the restoration of this activity with purified Cl suggests that direct classical pathway activation by GBS is not occurring by binding of the Cl INH nor cleavage and activation of C4 and C2. Results of our previous studies left these questions unanswered (4, 9, 15) .
We have now documented the initial role for Cl in direct activation of the classical complement pathway by type Ia GBS. Furthermore, we presented data on its critical role in antibody-dependent opsonization of type Ta GBS. In these experiments the addition of large amounts of hyperimmune rabbit antiserum to Cl-depleted serum did not restore opsonization of type Ta GBS. However, opsonization could be restored by inclusion of Cl with the antibody. Furthermore, Cl and antibody in combination resulted in greater restoration of opsonic activity to Cl-depleted serum that either component alone. This supports the role of the classical complement pathway in the enhancement of antibodymediated opsonization of type Ia GBS.
The significance of our findings on the requirement of Cl for initiating opsonization of type Ia GBS may be related to investigations on complement deficiencies in neonatal sera. Complement levels have been measured in neonatal sera, and these findings were correlated with opsonophagocytic capacity of the sera for type Ta GBS (10) . Deficient opsonophagocytic activity for type Ta GBS was correlated with low 50% hemolytic component levels and depressed classical complement pathway components Clq and C4. This is additional evidence for the role of Cl in initiating opsonization of type Ia GBS and points out the possible relation between decreased Cl levels in neonates and susceptibility to GBS disease.
